- 2017
-
Press releases - 01.03.2017
1 March 2017: A plan for action on violence against children
Wednesday 1 March 2017 will see the unveiling of the interministerial plan for “mobilisation and action on violence against children” by Laurence Rossignol, Minister for Families, Children and Women’s Rights.
-
Press releases - 01.03.2017
Sickle cell disease : remission of disease symptoms in the world’s first patient treated using gene therapy
A team led by Prof. Marina Cavazzana, working at Necker Hospital for Sick Children, AP-HP, and the Imagine Institute (AP-HP/Inserm/Paris Descartes University) performed gene therapy on a 13-year-old patient with severe sickle cell anaemia in October 2014 as part of a phase I/II clinical trial. Conducted in collaboration with Prof. Philippe Leboulch (CEA/Faculties of Medicine at Paris-Sud and Harvard Universities), who developed the vector used, and supervised the preclinical studies, this innovative treatment provided complete remission from the clinical signs of the disease, and the correction of biological signs. Results (15-month follow up after transplantation) are published in the New England Journal of Medicine on 2 March 2017, and confirm the efficacy of this new therapy of the future.
-
What's on? - 01.03.2017
1 March 2017: A plan for action on violence against children
Wednesday 1 March 2017 will see the unveiling of the interministerial plan for “mobilisation and action on violence against children” by Laurence Rossignol, Minister for Families, Children and Women’s Rights. Since early this year, the news has been marked by a series of infanticides in France. Although child abuse affects children from all backgrounds, official […]
-
Press releases - 23.02.2017
Multiple sclerosis : Mission Regeneration !
Why does multiple sclerosis progress more rapidly in some patients than others? Why do some patients with MS manage to regenerate their myelin, while others do not? Inserm researchers at Unit 1127, “Brain and Spine Institute” (Inserm/CNRS/UPMC) have demonstrated that lymphocytes play a major role in the remyelination process, and that they could possibly be exploited to develop new myelin regeneration strategies.
-
Press releases - 22.02.2017
28 February 2017: International Rare Disease Day
The 28 February 2017 marks the 10th edition of World Rare Disease Day, with the slogan “Join us in making the voice of rare diseases heard.” While there are 7,000 known rare diseases, 80% of them genetic in origin, new rare diseases are regularly discovered.
-
What's on? - 22.02.2017
28 February 2017: International Rare Disease Day
© rarediseaseday.org The 28 February 2017 marks the 10th edition of World Rare Disease Day, with the slogan “Join us in making the voice of rare diseases heard.” While there are 7,000 known rare diseases, 80% of them genetic in origin, new rare diseases are regularly discovered. According to the definition used in Europe, a disease […]
-
Press releases - 21.02.2017
Epidemics: urgent need for action
Inserm and the Coalition for Epidemic Preparedness Innovations (CEPI) are holding a large conference entitled “Vaccines Against Emerging Infections – a Global Insurance” on 21 and 22 February 2017. It is especially aimed at emphasising the urgent need for action and the potential for developing vaccines in the area of world epidemic crises. François Hollande, President of France, attended this conference today, along with Yves Levy, Chairman and CEO of Inserm, underscoring the major commitment of French research in this area.
-
Press releases - 20.02.2017
French institutions back the March for Science
On April 22, Earth Day 2017, the citizens of the world are invited to participate in a massive “March for Science.” The initiative was launched by US scientists in response to “new policies [that] threaten to further restrict scientists’ ability to carry out research and communicate their findings.”
-
Press releases - 10.02.2017
Epstein-Barr virus and cancer: new tricks from an old dog
Scientists estimate that approximately 95 percent of adults around the world are infected with the Epstein-Barr virus. In rare cases, an infection with this virus causes cancer. Scientists at the German Cancer Research Center (DKFZ), at the German Center for Infection Research (DZIF), and at the French National Institute of Health and Medical Research (Inserm) have now discovered that a component of the Epstein-Barr virus infectious particle promotes carcinogenesis. This viral protein interferes with cell division and impairs proper distribution of the genetic material to the two daughter cells. This confers a risk of subsequent cancer development.
-
Press releases - 08.02.2017
Socioeconomic environment and incidence of cancer in France
Almost 15,000 cases of cancer could be prevented in France each year by improving living conditions and promoting health among the most vulnerable populations. These were the conclusions of a study published in the weekly epidemiological report Bulletin épidémiologique hebdomadaire (BEH), and coordinated by Inserm Unit 1086 “Cancer and Prevention” located in Caen.